Ganz ML, Smalarz AM, Krupski TL et al: Economic Costs of Overactive Bladder in the United States. Urology 2010: 75(3): 526-532.
Gormley, E. A., Lightner, D. J., Burgio, K. L., Chai, T. C., Clemens, J. C., Culkin, D. J., Das, A. K., Foster, Jr., H. E., Scarpero, H. M., Tessier, C. D., Vasavada, S. P.: Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) In Adults: AUA/SUFU Guideline. American Urological Association Education and Research, Inc. ©2012|Amended 2019, available online at: http://www.auanet.org/education/guidelines/overactive-bladder.cfm
Haylen BT, de Ridder D, Freeman RM et al: An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourology and Urodynamics 2010; 29: 4-20.
Wearable Neuromodulation System for Overactive bladder (AOB): A Preferred Treatment Option. Ganesan, M, Tarver M. SUFU oral poster. Feb 2021.
Images of FemPulse device copyright Ken Gutmaker Photography, used by permission.
Image of Alexandra Haessler, MD copyright Tom Seawell, used by permission.
FemPulse and The Elegant Solution are trademarks of FemPulse Corporation
Other companies, products, and journals referenced on this site are registered or unregistered trademarks of their respective owners.